Track: Psychopharmacology and Pharmacotherapy

Novel Drug Development and
Mechanisms:
- Innovations in antidepressants, antipsychotics,
and anxiolytics, including rapid-acting agents like ketamine and
esketamine.
- Development of psychedelic-assisted therapies,
such as psilocybin and MDMA, for treatment-resistant disorders.
- Exploration of GABAergic and glutamatergic
pathways in new drug formulations.
Personalized Psychopharmacology:
- The role of pharmacogenomics in tailoring
psychiatric medications to individual genetic profiles.
- Understanding how biomarkers and endophenotypes
guide personalized treatment plans.
- Case studies showcasing the application of
precision psychiatry in clinical practice.
Treatment-Resistant Psychiatric
Disorders:
- Strategies for managing treatment-resistant
depression (TRD), schizophrenia, and bipolar disorder.
- The use of combination therapies and augmentation
strategies, such as lithium or atypical antipsychotics.
- Evaluation of adjunctive therapies, including
neurostimulatory treatments like ECT and TMS.
Pharmacotherapy in Special
Populations:
- Approaches to psychopharmacology in children,
adolescents, pregnant women, and older adults.
- Addressing the unique challenges in managing
polypharmacy and drug interactions in elderly patients.
- Ethical considerations in prescribing psychotropic
medications to vulnerable populations.
Neuroinflammation and Immune
Modulation:
- Investigating the role of anti-inflammatory agents
and immune modulators in treating psychiatric conditions.
- Exploring the cytokine hypothesis of depression
and its implications for psychopharmacology.
- Advances in the use of anti-inflammatory drugs in
managing neuroinflammation linked to mental health disorders.
Safety, Efficacy, and Side Effect
Management:
- Monitoring and managing the adverse effects of
psychotropic medications, including metabolic syndrome and extrapyramidal
symptoms.
- Strategies for minimizing sedation, weight gain,
and other common side effects of psychiatric medications.
- The role of digital tools in tracking medication
adherence and side effects.
Integrated Approaches: Combining
Medication with Psychotherapy:
- Synergistic effects of combining pharmacotherapy
with cognitive-behavioral therapy (CBT), DBT, or other psychological
interventions.
- Examining the efficacy of integrated approaches in
treating anxiety disorders, PTSD, and OCD.
- Case studies highlighting the role of combined
therapies in improving patient outcomes.
Future Directions in
Psychopharmacology:
- Emerging trends in neuropharmacology, including
nanotechnology and targeted drug delivery systems.
- Potential of AI and machine learning in drug
discovery and predicting treatment responses.
- Ethical considerations in the development and
application of new psychotropic drugs.
Learning Outcomes:
- Understand the latest developments in
psychopharmacology and their implications for psychiatric treatment.
- Explore the role of precision medicine and
pharmacogenomics in enhancing treatment outcomes.
- Learn strategies for managing treatment-resistant
conditions and minimizing adverse effects.
- Gain insights into emerging therapies, such as
psychedelics, immune modulators, and neurostimulatory techniques.
- Discuss the benefits of integrating pharmacotherapy
with psychotherapeutic interventions for holistic patient care.
Scientific Highlights
- Psychology and Psychiatry
- Psychology of Brain Aging and Emotional Well-Being
- Psychopathology
- Psychiatric Immunology and Physiological Psychology
- Cognitive and Behavioural Science
- Psychopharmacology and Pharmacotherapy
- AI and Machine Learning in Mental Health
- Psychological Interventions
- Clinical Psychology and Psychotherapy
- Psychological Case Studies in Mental Health
- Child and Adolescent Psychiatry
- Women's Mental Health
- Health, Stress, and Coping
- Psychiatric Nursing
- Intellectual Disabilities
- Psychology Impact of COVID-19 on Mental Health
- Stroke, Trauma, and Epilepsy
- Applied Psychology
- Clinical Trials and New Frontiers in Psychotherapy